Drug
Romosozumab
Romosozumab: highest development phase Phase 1, developed by Amgen. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Amgen
Trials
| Drug | Phase | Indication |
|---|---|---|
| Romosozumab NCT00950950 | Phase 1 | Osteopenia |
Latest
No recent events.
Follow Romosozumab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.